Insyn2b | inhibitory synaptic factor family member 2B
Physiological systems
17 / 24 physiological systems tested
4 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system Hematopoietic system Behavior/neurological
13 No significant impact
7 Not tested
Data collections
Gene metrics:5Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
hyperactivity | 6 supporting datasets | Insyn2bem1(IMPC)J | homozygote | Early adult | 3.83x10-8 | ||
increased circulating alanine transaminase level | 1 supporting dataset | Insyn2bem1(IMPC)J | homozygote | Early adult | 1.98x10-5 | ||
increased leukocyte cell number | 1 supporting dataset | Insyn2bem1(IMPC)J | homozygote | Early adult | 1.26x10-5 | ||
decreased circulating phosphate level | 1 supporting dataset | Insyn2bem1(IMPC)J | homozygote | Early adult | 2.44x10-5 | ||
increased circulating glucose level | 1 supporting dataset | Insyn2bem1(IMPC)J | homozygote | Early adult | 1.24x10-8 |
| | | | | | | | | |
Human diseases caused by Insyn2b mutations
The analysis uses data from IMPC, along with published data on other mouse mutants, in comparison to human disease reports in OMIM, Orphanet, and DECIPHER.
Phenotype comparisons summarize the similarity of mouse phenotypes with human disease phenotypes.
External links
No external links available for Insyn2b.